Loading...

Discounted Cash Flow (DCF) Analysis Levered


Atrion Corporation

Atrion Corporation (ATRI)

Healthcare

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 131.9911.652.062.048.17152.43729.033,486.8016,676.6879,761.24381,482.07
Revenue (%)
Operating Cash Flow 36.5831.2240.4337.4047.0443.235,702.5427,274.13130,446.69623,900.422,983,990.94
Operating Cash Flow (%)
Capital Expenditure 7.5012.679.3210.649.6817.511,479.717,077.1733,848.67161,891.40774,294.17
Capital Expenditure (%)
Free Cash Flow 44.0743.8949.7548.0456.7160.747,182.2634,351.29164,295.35785,791.823,758,285.11

Weighted Average Cost Of Capital

Share price $ 662
Diluted Shares Outstanding 0.00
Cost of Debt
Tax Rate 18.51
After-tax Cost of Debt -0.88
Risk-Free Rate
Market Risk Premium
Cost of Equity 3.55
Total Debt -
Total Equity 1.23
Total Capital 1.23
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 131.9911.652.062.048.17152.43729.033,486.8016,676.6879,761.24381,482.07
Operating Cash Flow 36.5831.2240.4337.4047.0443.235,702.5427,274.13130,446.69623,900.422,983,990.94
Capital Expenditure 7.5012.679.3210.649.6817.511,479.717,077.1733,848.67161,891.40774,294.17
Free Cash Flow 44.0743.8949.7548.0456.7160.747,182.2634,351.29164,295.35785,791.823,758,285.11
WACC
PV LFCF 6,936.0332,036.34147,970.44683,450.543,156,742.86
SUM PV LFCF 3,266,865.05

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 3.55
Free cash flow (t + 1) Infinity
Terminal Value -Infinity
Present Value of Terminal Value -Infinity

Intrinsic Value

Enterprise Value -
Net Debt -68.44
Equity Value -
Shares Outstanding 0.00
Equity Value Per Share -390,899,578,119.67